>

Demant Stock Today

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 40px;;'>DEM</div>
Demant AS has about a 41 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 30 days. Equity ratings for Demant AS are calculated based on the Macroaxis scoring framework. The performance scores are derived for the period starting the 10th of January 2020 and ending today, the 9th of April 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores
Demant AS cannot be verified against its exchange. It appears that Demant AS is not available for investing at the moment. Please verify the symbol is currently traded on Copenhagen Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Demant AS Profile

Demant AS, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance peoples hearing in Europe, North America, the Pacific, Asia, and internationally. Demant AS was founded in 1904 and is headquartered in Smrum, Denmark. Demant AS operates under Medical Instruments Supplies classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 14614 people.. The public information regarding Demant AS's current market price is not available at this time.
Legal NameDemant AS
CEOSoeren NielsenView All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Demant AS (DEMANT) is traded on Copenhagen Stock Exchange in Denmark and employs 14,614 people. The company currently falls under 'Large-Cap' category with current market capitalization of 47.86 B. Demant AS operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 245.29 M outstanding shares. The company has accumulated about 630 M in cash with 1.68 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.57.
Check Demant AS Probability Of Bankruptcy

Demant Stock Top Holders

Demant Stock Against Markets

Demant AS cannot be verified against its exchange. It appears that Demant AS is not available for investing at the moment. Please verify the symbol is currently traded on Copenhagen Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

Demant AS Corporate Directors

Thomas Duer Director, Staff-elected
Peter Foss Director
Joergen Nielsen Director, Staff-elected
Check out Investing Opportunities. Please also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page